Y. Hara, “Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer”, World J Oncol, vol. 16, no. 4, pp. 347–356, Jul. 2025, doi: 10.14740/wjon2583.